Geoffrey M. Parker, Director at ChemoCentryx, Inc. (CCXI), sold 61,910 shares at $60.20 ($3.5M) on 2021-03-04, disclosed to the SEC on 2021-03-08.
Open-market sale of $3.5M CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.20 | 1,910 | $115K | 3.3% |
| 2 | $55.89 | 13,330 | $745K | 21.3% |
| 3 | $55.89 | 13,330 | $745K | 21.3% |
| 4 | $56.78 | 16,670 | $947K | 27.1% |
| 5 | $56.78 | 16,670 | $947K | 27.1% |
| Total | $56.50 avg | 61,910 |
| $3.5M |
| 100% |
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |